Cargando…
A Change of Heart: Human Cardiac Tissue Engineering as a Platform for Drug Development
PURPOSE OF REVIEW: Human cardiac tissue engineering holds great promise for early detection of drug-related cardiac toxicity and arrhythmogenicity during drug discovery and development. We describe shortcomings of the current drug development pathway, recent advances in the development of cardiac ti...
Autores principales: | Bremner, Samantha B., Gaffney, Karen S., Sniadecki, Nathan J., Mack, David L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897733/ https://www.ncbi.nlm.nih.gov/pubmed/35247166 http://dx.doi.org/10.1007/s11886-022-01668-7 |
Ejemplares similares
-
3D Printing Approaches to Engineer Cardiac Tissue
por: Lu, Ting-Yu, et al.
Publicado: (2023) -
Four Dimensions of the Cardiac Myocyte Epigenome: from Fetal to Adult Heart
por: Rommel, Carolin, et al.
Publicado: (2020) -
Role of Mononuclear Cardiomyocytes in Cardiac Turnover and Regeneration
por: Becker, Cora, et al.
Publicado: (2020) -
Model Systems for Addressing Mechanism of Arrhythmogenesis in Cardiac Repair
por: Zhang, Xiao-Dong, et al.
Publicado: (2021) -
Formation of the Heart: Defining Cardiomyocyte Progenitors at Single-Cell Resolution
por: Tyser, Richard C. V.
Publicado: (2023)